prosigna

Project objectives

The research aims to compare the pathological data and compare them with the PROSIGNA test so as to accurately define the subpopulations of patients affected by breast cancer for which the evaluation of the anatomopathologist is sufficient in order to establish the optimal therapeutic path, and those instead for which the definition of the molecular profile is essential. These data will generate scientific evidence to support and objectify the future choices of the NHS in order to introduce the reimbursement of the molecular test on breast cancer.

Start and end date

Project Manager

Coordinating institution of the project

Other Institutions involved

• University of Barcelona

Funding source(s).

Economic value of the project

90.000 €